Insider Trading activities of Synthorx, Inc. (THOR)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Synthorx, Inc. (THOR) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Synthorx, Inc. since year 2005. Table 2 shows the detailed insider transactions of Synthorx, Inc. since 2005. The reporting company's ticker symbol is THOR. The reporting company's CIK number is 1609727.
The total value of stock buying since 2005 is $148,000,017.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $15,750.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Synthorx, Inc. (THOR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-01 0 $0 0 $0 25,000 $15,750
2018-12 13,454,547 $148,000,017 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Synthorx, Inc. insiders (THOR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-01-24 Shawver Laura (President and CEO) Option Ex 25,000 .63 15,750
2018-12-11 Avalon X Spv, L.p. (10% Owner) Buy 545,455 11.00 6,000,005
2018-12-11 Orbimed Capital Gp Vii Llc (10% Owner) Buy 1,363,636 11.00 14,999,996
2018-12-11 Reardon Tighe (Acting Chief Financial Officer) Buy 545,455 11.00 6,000,005
2018-12-11 Kolchinsky Peter Buy 4,545,455 11.00 50,000,005
2018-12-11 Lichter Jay (Director) Buy 545,455 11.00 6,000,005
2018-12-11 Thompson Peter A. (Director) Buy 1,363,636 11.00 14,999,996
2018-12-11 Ra Capital Healthcare Fund Lp Buy 4,545,455 11.00 50,000,005

Insider trading activities including stock purchases, stock sales, and option exercises of THOR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Synthorx, Inc. (symbol THOR, CIK number 1609727) see the Securities and Exchange Commission (SEC) website.